s6y Starling Oncology, Inc. EFFECT

Starling Oncology, Inc. EFFECT, filed Sep 26, 2022: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 26, 2022 4:30 P.M.
Form: S-1
CIK: 0001799191
Company Name: Oncology Institute, Inc.
File Number: 333-267324